Moorman PG - Search Results

1

Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.

Peres LC, Bethea TN, Camacho TF, Bandera EV, Beeghly-Fadiel A, Chyn DL, Harris HR, Joslin CE, Moorman PG, Myers E, Ochs-Balcom HM, Rosenow W, Setiawan VW, Wu AH, Rosenberg L, Schildkraut JM. Peres LC, et al. Among authors: moorman pg. J Natl Cancer Inst. 2021 Jun 1;113(6):710-718. doi: 10.1093/jnci/djaa188. J Natl Cancer Inst. 2021. PMID: 33252629 Free PMC article.

2

Oral contraceptives and breast cancer among African-american women and white women.

Moorman PG, Millikan RC, Newman B. Moorman PG, et al. J Natl Med Assoc. 2001 Sep;93(9):329-34. J Natl Med Assoc. 2001. PMID: 11560288 Free PMC article.

3

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.

Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Schildkraut JM, et al. Among authors: moorman pg. J Natl Cancer Inst. 2002 Jan 2;94(1):32-8. doi: 10.1093/jnci/94.1.32. J Natl Cancer Inst. 2002. PMID: 11773280

4

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Moorman PG, et al. Cancer Causes Control. 2002 Nov;13(9):807-11. doi: 10.1023/a:1020678100977. Cancer Causes Control. 2002. PMID: 12462545

5

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Among authors: moorman pg. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

6

Racial differences in enrolment in a cancer genetics registry.

Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM. Moorman PG, et al. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1349-54. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298957

7

IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.

Schildkraut JM, Demark-Wahnefried W, Wenham RM, Grubber J, Jeffreys AS, Grambow SC, Marks JR, Moorman PG, Hoyo C, Ali S, Walther PJ. Schildkraut JM, et al. Among authors: moorman pg. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):403-8. doi: 10.1158/1055-9965.EPI-04-0426. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734965

8

Antidepressant medication use [corrected] and risk of ovarian cancer.

Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Moorman PG, et al. Obstet Gynecol. 2005 Apr;105(4):725-30. doi: 10.1097/01.AOG.0000157113.98061.eb. Obstet Gynecol. 2005. PMID: 15802397

9

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A. Spillman MA, et al. Gynecol Oncol. 2005 May;97(2):543-9. doi: 10.1016/j.ygyno.2005.01.025. Gynecol Oncol. 2005. PMID: 15863158

10

Menopausal hormones and risk of ovarian cancer.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A. Moorman PG, et al. Am J Obstet Gynecol. 2005 Jul;193(1):76-82. doi: 10.1016/j.ajog.2004.11.013. Am J Obstet Gynecol. 2005. PMID: 16021062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page